The North America Flexible Endoscopic Surgery Robot Market was valued at USD 346 million in 2024 and is estimated to grow at a CAGR of 14.9% to reach USD 1.4 billion by 2034.
The market is experiencing strong momentum due to increasing preference for minimally invasive procedures, a surge in surgical volumes, and continuous technological evolution in robotic systems. Advancements in AI-driven navigation, enhanced robotic articulation, and 3D visualization are revolutionizing the way endoscopic surgeries are performed. These innovations are improving procedural accuracy, surgeon dexterity, and overall patient safety. Artificial intelligence and machine learning are also transforming the field by allowing real-time decision-making during surgery, enabling predictive insights, and improving identification of complex tissue structures. The expanding prevalence of chronic health conditions such as colorectal and respiratory diseases across the region is further driving the demand for robotic-assisted interventions. North America’s strong healthcare infrastructure, widespread adoption of medical robotics, and consistent clinical success rates are boosting market growth. With hospitals and surgical centers increasingly prioritizing efficiency, precision, and patient outcomes, the demand for flexible robotic endoscopy platforms continues to escalate, establishing the region as a global leader in this sector.
The therapeutic segment held a 59.3% share in 2024. Its dominance is attributed to growing utilization of robotic-assisted systems for complex therapeutic procedures that demand precision and control. These systems provide surgeons with enhanced dexterity, stable navigation, and high-definition visualization, which together allow intricate procedures to be performed with minimal invasiveness. Their use supports faster recovery, less postoperative pain, and reduced complication rates, further propelling clinical acceptance and market expansion across a wide range of treatment settings.
The urology segment held a share of 42.4% in 2024 and is forecasted to reach USD 583.6 million by 2034. The increasing incidence of urinary tract disorders, kidney diseases, and prostate-related conditions has accelerated the adoption of robotic-assisted techniques within urology. Robotic technology allows for improved surgical precision and reduced trauma in operations involving the kidneys, bladder, and prostate. The benefits of reduced blood loss, smaller incisions, and shorter recovery times continue to encourage hospitals and surgical units to expand robotic capabilities for urological care.
U.S Flexible Endoscopic Surgery Robot Market reached USD 326.4 million in 2024. Its dominance stems from high healthcare spending, widespread technological adoption, and an advanced hospital network equipped for robotic surgery integration. The country benefits from a robust ecosystem of manufacturers, research centers, and clinical innovators that accelerate product development and adoption. Rising rates of digestive and gastrointestinal disorders in the U.S. are further stimulating demand for minimally invasive robotic endoscopic procedures designed to enhance patient safety and accelerate recovery timelines.
Prominent companies operating in the North America Flexible Endoscopic Surgery Robot Market include Medtronic, Intuitive Surgical, CMR Surgical, Johnson & Johnson, Medrobotics, GI View, Endo Tools Therapeutics, and Asensus Surgical. To strengthen their North America Flexible Endoscopic Surgery Robot Market foothold, leading manufacturers in the North America flexible endoscopic surgery robot industry are focusing on innovation, strategic partnerships, and product diversification. Companies are investing heavily in R&D to develop smaller, more cost-effective robotic platforms that offer improved ergonomics and enhanced maneuverability. Collaborations with hospitals and surgical training centers are being expanded to accelerate adoption and gather real-world performance data. Firms are also integrating artificial intelligence and cloud-based analytics into robotic systems to enable smarter navigation and outcome optimization.
This product will be delivered within 2-4 business days.
The market is experiencing strong momentum due to increasing preference for minimally invasive procedures, a surge in surgical volumes, and continuous technological evolution in robotic systems. Advancements in AI-driven navigation, enhanced robotic articulation, and 3D visualization are revolutionizing the way endoscopic surgeries are performed. These innovations are improving procedural accuracy, surgeon dexterity, and overall patient safety. Artificial intelligence and machine learning are also transforming the field by allowing real-time decision-making during surgery, enabling predictive insights, and improving identification of complex tissue structures. The expanding prevalence of chronic health conditions such as colorectal and respiratory diseases across the region is further driving the demand for robotic-assisted interventions. North America’s strong healthcare infrastructure, widespread adoption of medical robotics, and consistent clinical success rates are boosting market growth. With hospitals and surgical centers increasingly prioritizing efficiency, precision, and patient outcomes, the demand for flexible robotic endoscopy platforms continues to escalate, establishing the region as a global leader in this sector.
The therapeutic segment held a 59.3% share in 2024. Its dominance is attributed to growing utilization of robotic-assisted systems for complex therapeutic procedures that demand precision and control. These systems provide surgeons with enhanced dexterity, stable navigation, and high-definition visualization, which together allow intricate procedures to be performed with minimal invasiveness. Their use supports faster recovery, less postoperative pain, and reduced complication rates, further propelling clinical acceptance and market expansion across a wide range of treatment settings.
The urology segment held a share of 42.4% in 2024 and is forecasted to reach USD 583.6 million by 2034. The increasing incidence of urinary tract disorders, kidney diseases, and prostate-related conditions has accelerated the adoption of robotic-assisted techniques within urology. Robotic technology allows for improved surgical precision and reduced trauma in operations involving the kidneys, bladder, and prostate. The benefits of reduced blood loss, smaller incisions, and shorter recovery times continue to encourage hospitals and surgical units to expand robotic capabilities for urological care.
U.S Flexible Endoscopic Surgery Robot Market reached USD 326.4 million in 2024. Its dominance stems from high healthcare spending, widespread technological adoption, and an advanced hospital network equipped for robotic surgery integration. The country benefits from a robust ecosystem of manufacturers, research centers, and clinical innovators that accelerate product development and adoption. Rising rates of digestive and gastrointestinal disorders in the U.S. are further stimulating demand for minimally invasive robotic endoscopic procedures designed to enhance patient safety and accelerate recovery timelines.
Prominent companies operating in the North America Flexible Endoscopic Surgery Robot Market include Medtronic, Intuitive Surgical, CMR Surgical, Johnson & Johnson, Medrobotics, GI View, Endo Tools Therapeutics, and Asensus Surgical. To strengthen their North America Flexible Endoscopic Surgery Robot Market foothold, leading manufacturers in the North America flexible endoscopic surgery robot industry are focusing on innovation, strategic partnerships, and product diversification. Companies are investing heavily in R&D to develop smaller, more cost-effective robotic platforms that offer improved ergonomics and enhanced maneuverability. Collaborations with hospitals and surgical training centers are being expanded to accelerate adoption and gather real-world performance data. Firms are also integrating artificial intelligence and cloud-based analytics into robotic systems to enable smarter navigation and outcome optimization.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Category, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Country, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this North America Flexible Endoscopic Surgery Robot market report include:- Asensus Surgical
- CMR Surgical
- Endo Tools Therapeutics
- GI View
- Intuitive Surgical
- Johnson & Johnson
- Medrobotics
- Medtronic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | October 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 346 Million |
| Forecasted Market Value ( USD | $ 1400 Million |
| Compound Annual Growth Rate | 14.9% |
| Regions Covered | North America |
| No. of Companies Mentioned | 8 |
